Hans-Georg Kopp

Hans-Georg Kopp

Robert Bosch Hospital - Stuttgart / Germany
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4963398
person_outline Hans-Georg Kopp's MOST POPULAR ARTICLES
1-) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced … SE Al-Batran, N Homann, C Pauligk, TO Goetze, J Meiler, S Kasper, ... The Lancet 393 (10184), 1948-1957, 2019 12812019
2-) Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small … H West, M McCleod, M Hussein, A Morabito, A Rittmeyer, HJ Conter, ... The Lancet Oncology 20 (7), 924-937, 2019 9572019
3-) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes DK Jin, K Shido, HG Kopp, I Petit, SV Shmelkov, LM Young, AT Hooper, ... Nature medicine 12 (5), 557-567, 2006 7682006
4-) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients …SE Al-Batran, RD Hofheinz, C Pauligk, HG Kopp, GM Haag, KB Luley, ...The lancet oncology 17 (12), 1697-1708, 20167852016
5-) The bone marrow vascular niche: home of HSC differentiation and mobilizationHG Kopp, ST Avecilla, AT Hooper, S RafiiPhysiology 20 (5), 349-356, 20057242005